Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;81(6):923-930.
doi: 10.1016/j.jinf.2020.10.023. Epub 2020 Oct 27.

Prior presumed coronavirus infection reduces COVID-19 risk: A cohort study

Affiliations

Prior presumed coronavirus infection reduces COVID-19 risk: A cohort study

Dvir Aran et al. J Infect. 2020 Dec.

Abstract

Background: Immunological cross-reactivity between common cold coronaviruses (CCC) and SARS-CoV-2 might account for the reduced incidence of COVID-19 in children. Evidence to support speculation includes in vitro evidence for humoral and cellular cross-reactivity with SARS-CoV-2 in specimens obtained before the pandemic started.

Method: We used retrospective health insurance enrollment records, claims, and laboratory results to assemble a cohort of 869,236 insured individuals who had a PCR test for SARS-CoV-2. We estimated the effects of having clinical encounters for various diagnostic categories in the year preceding the study period on the risk of a positive test result.

Findings: After adjusting for age, gender and care seeking behavior, we identified that individuals with diagnoses for common cold symptoms, including acute sinusitis, bronchitis, or pharyngitis in the preceding year had a lower risk of testing positive for SARS-CoV-2 (OR=0.76, 95%CI=0.75, 0.77). No reduction in the odds of a positive test for SARS-CoV-2 was seen in individuals under 18 years. The reduction in odds in adults remained stable for four years but was strongest in those with recent common cold symptoms.

Interpretation: While this study cannot attribute this association to cross-immunity resulting from a prior CCC infection, it is one potential explanation. Regardless of the cause, the reduction in the odds of being infected by SARS-CoV-2 among those with a recent diagnosis of common cold symptoms may have a role in shifting future COVD-19 infection patterns from endemic to episodic.

Keywords: Common cold; Covid-19; Cross reactive; SARS-Cov-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Drs. Overhage, Beachler and Lanes are employees of HealthCore Inc., a subsidiary of Anthem Inc. Dr. Aran is a consutlant for Anthem Innovation Israel. None of the authors have any competing interests.

Figures

Fig. 1
Fig. 1
Study cohort. A) Individuals that were not enrolled for 12 months prior the SARS-CoV-2 test were excluded. B) The age (left) and gender (right) distributions of individuals with positive and negative PCR tests for SARS-CoV-2 were similar. 15.1% of the individuals in the cohort were SARS-CoV-2 positive.
Fig. 2
Fig. 2
Phenotypes and diagnoses associated with a positive SARS-CoV-2 test. A) A volcano plot of the effect size of prevalent diagnostic categories on SARS-CoV-2 PCR test positivity and significance (log scale). The size of the circle is proportional to the number of individuals with the phenotype, and red circles indicate significance (p < 1e-20). -log10(p-values are capped at 100. B) A volcano plot of the effect size of prevalent ICD-10 diagnosis codes on SARS-CoV-2 PCR test positivity and significance (log scale). The size of the circle is proportional to the number of individuals with the phenotype, and red circles indicate significance (p < 1e-15).
Fig. 3
Fig. 3
Individuals with common cold symptom diagnoses. Age (A) and gender (B) distributions of 126,998 patients with acute sinusitis, acute bronchitis, or acute pharyngitis ICD-10 codes were similar in individuals with positive and negative SARS-CoV-2 PCR tests. C) The overlap of ICD-10 diagnosis codes, percentage from the cohort, and delta SARS-CoV-2 positive rate for each of the symptoms and combined, stratified by age. (D) Odds ratios for having a positive PCR test for SARS-CoV-2, stratified by age.
Fig. 5
Extended Figure 1
Age stratification. Odds ratios for having a positive PCR test for SARS-CoV-2, stratified by age groups.
Fig. 6
Extended Figure 2
Fig. 5
Extended Figure 3
Fig. 4
Fig. 4
Protective effect of common cold symptoms over time. Thirty-day moving average of the temporal association between the last date the ICD-10 diagnosis code was recorded and the PCR test for SARS-CoV-2 in 2020.

Comment in

References

    1. Paules C.I., Marston H.D., Fauci A.S. Coronavirus infections—more than just the common cold. JAMA. 2020;323(8):707–708. - PubMed
    1. de Wilde A.H., Snijder E.J., Kikkert M., van Hemert M.J. Roles of host gene and non-coding RNA expression in virus infection. Springer; 2017. Host factors in coronavirus replication; pp. 1–42.
    1. De Wit E., Van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523. - PMC - PubMed
    1. Gorse G.J., Patel G.B., Vitale J.N., O'Connor T.Z. Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum. Clin Vaccine Immunol. 2010;17(12):1875–1880. - PMC - PubMed
    1. Killerby M.E., Biggs H.M., Haynes A., Dahl R.M., Mustaquim D., Gerber S.I. Human coronavirus circulation in the United States 2014–2017. J Clin Virol. 2018;101:52–56. - PMC - PubMed

MeSH terms